All News about 4D Molecular Therapeutics Inc
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
What 4 Analyst Ratings Have To Say About 4D Molecular Therapeutics
February 07, 2024
Via Benzinga
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](https://cdn.benzinga.com/files/images/story/2024/06/07/RGNX.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/06/06/bz-pharma-briefs_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/06/06/xrdDAFlJKNXbrw2-j4527636209394207909-t23_0.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
4DMT to Participate in Upcoming Investor Conferences
June 03, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](https://investorplace.com/wp-content/uploads/2024/02/fdmt1600.png)
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
4DMT to Participate in Upcoming Investor Conference
May 07, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](https://cdn.benzinga.com/files/images/story/2024/04/18/Untitled-design---2024-04-19T000043-938.png?width=1200&height=800&fit=crop)
To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
April 18, 2024
Via Benzinga
Topics
ETFs
![](https://cdn.benzinga.com/files/images/story/2024/laboratory-217041-1280_0.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
4DMT to Participate in Upcoming Investor Conferences
March 04, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
4DMT Reports Full Year 2023 Financial Results and Operational Highlights
February 29, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](https://cdn.benzinga.com/files/images/story/2024/Eyes_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/chart-1905225_0.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](https://cdn.benzinga.com/files/images/story/2024/laboratory-563423-1920_5.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.